Kytopen Names Michael Chiu, Ph.D., as Chief Executive Officer

Company Adds Proven Product Development and Commercial Leader as it Accelerates Launch of Flowfect® Cell Engineering Technology CAMBRIDGE, Mass., Aug. 7, 2023 -- (Healthcare Sales & Marketing Network) -- Kytopen, a biotechnology company that develo... Biopharmaceuticals, Personnel Kytopen, Flowfect, microfluidics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news